跳至主要内容
临床试验/ACTRN12620000526976
ACTRN12620000526976招募中未知

Evaluation of Point Of Care Hepatitis C testing and subsequent treatment uptake in injecting drug users visiting a medically Supervised Injecting Room – a pilot study (EPOCH-SIR)

Gastroenterology Department, St Vincent's Hospital Melbourne0 个研究点目标入组 1,500 人开始时间: 2020年4月29日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Aged greater than or equal to 18 years;
  • - Present to the medically supervised injecting room during the recruitment phase of the study;
  • - Able to provide written informed consent;
  • - Consent to provide full name, contact details and Medicare number;
  • - Consent to multiple visits and to completion of questionnaires;
  • - Consent to blood sample for storage at pre-specified time points during the study;
  • - Not currently engaged in care for treatment of hepatitis C infection, hepatitis B or HIV;
  • - Fulfills study criteria for hepatitis C diagnosis to initiate treatment.

排除标准

  • - Pregnant or breastfeeding at time of commencement of hepatitis C antiviral treatment;
  • - Clinical evidence of decompensated cirrhosis;
  • - Diagnosed and/or undergoing treatment for hepatocellular carcinoma;
  • - Awaiting liver transplantation;
  • - Currently engaged in care for treatment of hepatitis C infection, hepatitis B infection or HIV;
  • - Unable or unwilling to present to pick up ongoing DAA supply for treatment (four weekly basis);
  • - Receiving medications which are contra-indicated to co-administration of direct acting antiviral's or at risk of significant drug-drug interactions;
  • - Clients who are first time presenters or users of the medically supervised injecting room
  • - Clients who receive a clinical intervention for overdose whilst using the supervised injecting drug room after initially consenting to participate;
  • - Evidence of any condition, therapy, laboratory abnormality or other circumstance (current or prior) that may confound the study’s results, or interfere with participation for the full duration of the study, such that it is not in the best interest of the participant.

研究者

发起方
Gastroenterology Department, St Vincent's Hospital Melbourne

相似试验